BDSX Q2 2019 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$138M

Q2 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$6M+20.8% YoY

Gross Profit

$5M77.8% margin

Operating Income

-$6M-96.3% margin

Net Income

-$7M-118.3% margin

EPS (Diluted)

$-6.40

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$40,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+20.8%
Gross Profit	$5M	$4M	+19.8%
Operating Income	-$6M	-$5M	-31.5%
Net Income	-$7M	-$7M	-11.6%